The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).
The investment seeks long-term growth of capital by investing primarily in common stocks of foreign companies.
To pursue its goal, the fund invests mainly in common stocks of foreign companies, including companies in developed and emerging markets. Under normal circumstances, at least 80% of the fund's net assets, plus the amount of any borrowings for investment purposes, will be invested in companies with a market capitalization greater than $2.5 billion at the time of purchase. It seeks to reduce risk by diversifying among many companies and industries.
The average market capitalization across the Neuberger Berman International Sel A MF is 121.52B. The market cap for tickers in the group ranges from 3.51M to 371.79B. ASML holds the highest valuation in this group at 371.79B. The lowest valued company is NOVN at 3.51M.
The average weekly volume growth across all stocks in the Neuberger Berman International Sel A MF was -61%. For the same stocks of the MF, the average monthly volume growth was -73% and the average quarterly volume growth was -50%
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Valuation Rating: 57
P/E Growth Rating: 45
Price Growth Rating: 50
SMR Rating: 55
Profit Risk Rating: 38
Seasonality Score: 26 (-100 ... +100)